CANDICE BOBOLSKY: Open Payments
NPI 1952943334 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 51 payments from 16 companies in 2025. Trend: 2023 $561 · 2024 $734 · 2025 $1,258
Food & beverage: $1,174Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $308 |
| Janssen Biotech, Inc. | 5 | $233 |
| Madrigal Pharmaceuticals | 4 | $177 |
| Lilly USA, LLC | 1 | $98 |
| Ardelyx, Inc. | 2 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $70 |
| Celltrion USA Inc. | 3 | $55 |
| GENZYME CORPORATION | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $27 |
Products named: TREMFYA, REZDIFFRA, CREON, OMVOH, IBSRELA, RINVOQ, VEGZELMA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
